Patent · US Active

Compositions and methods for the treatment of immunodeficiency

US10683343B2 · kind B2 · utility

4Cited by
45References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 14, 2018
Grant dateJun 16, 2020
Priority date
Expiry dateMay 14, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compositions and methods for the treatment of immunodeficiency (e.g., primary immunodeficiency disease). In particular, the invention provides human plasma immunoglobulin compositions containing select antibody titers specific for a plurality of respiratory pathogens, methods of identifying human donors and donor samples for use in the compositions, methods of manufacturing the compositions, and methods of utilizing the compositions (e.g., for prophylactic administration and/or therapeutic treatment (e.g., passive immunization (e.g., immune-prophylaxis))).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.